Dasatinib blocks transcriptional and promigratory responses to transforming growth factor-beta in pancreatic adenocarcinoma cells through inhibition of Smad signalling: implications for in vivo mode of actionTobias Bartscht, Hendrik Ungefroren|Molecular Cancer|2015Cited by 34
Radiochemotherapy with or without cetuximab for unresectable esophageal cancer: final results of a randomized phase 2 trial (LEOPARD-2)Dirk Rades, Markus Moehler, Peter Hunold et al.|Strahlentherapie und Onkologie|2020Cited by 12